Obesity Therapy
Pyrimidine-diazabicyclo[3.3.0]octane series are 5-HT2C receptor agonists to combat obesity
Published in Obesity and Diabetes Week, July 3rd, 2006
According to recent research from the United States, "The 5-HT2C receptor has been implicated in the regulation of appetite."
"As such, small molecule agonists to this receptor may serve as novel therapies to combat obesity. We describe here the identification, synthesis, and SAR of a 5-HT2C agonist from a unique pyrimidine-diazabicyclo[3.3.0]octane series," wrote B.R. Huck and colleagues, Athersys Inc.
The researchers concluded, "This compound displayed good potency at the 5-HT2C receptor, modest selectivity relative to other 5-HT2...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Morbid Obesity
HOMA, QUICKI and MFfm offer insulin resistance measurement options in morbid obesity - Obesity Pathogenesis
Leptin may inhibit preadipocyte proliferation by modifying signals in nonadipose tissue - Obesity Pathogenesis
Macrophage-conditioned medium inhibits differentiation of 3T2-L1 and abdominal preadipocytes - Obesity Therapy
11 Beta-hydroxysteroid dehydrogenase type 1 inhibition reduces weight gain in obesity model - Atherosclerosis
Diet and exercise may improve coronary artery disease risk linked to metabolic syndrome - Business Update
Current industry-related news solidifies MediSys Corporation's medical model - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
